Strides Pharma Science Ltd
NSE: STAR BSE: 532531
₹893.95
(2.41%)
Thu, 12 Mar 2026, 05:04 am
Market Cap80.39B
PE Ratio16.11
Dividend0.46
Health Technology
Pharmaceuticals: Major
24.5KCompany History
2002
- Board approves allotment of 210,955 shares at Rs.10 to shareholders of Bombay Drugs & Pharmas Ltd.
- Zenith Pharmaceuticals acquires 71% shares through preferential issue.
- Board approves restructuring of Cram division into two companies.
- Strides incorporates Strides Africa Ltd in British Virgin Islands as wholly owned subsidiary.
- Board decides to change name to Strides Arcolab (FA).
2003
- Mr. Francis Pinto nominated as Director.
- Strides forges exclusive alliance with Aspen Pharmacare.
- Strides concludes agreement with Sorm Co. Ltd for generics, OTC, and nutraceutical supply.
- Strides appoints V. Hariharan as CFO, Joe Thomas as President, Krishna Kumar Menon as COO.
- Board approves reorganization of subsidiaries and write-off of investments.
- Strides inks MoU with Ribbon SRL for Cephalosporin.
2004
- Major fire occurs in private custom bonded warehouse in Mexico.
- Strides Arcolab enters MoU with BITS Pilani for off-campus program and launches STEP.
2005
- Strides Arcolab enters agreement with Mayne Pharma for six anti-infective products.
- Strides Arcolab enters agreement for private placement issue.
- Strides Arcolab signs license agreement with KV Pharma for 10 generic drugs in US and Canada.
- Strides Arcolab acquires sterile manufacturing facility in Poland.
2007
- Strides Arcolab receives USFDA tentative approval for Efavirenz tablets.
- Strides Arcolab receives 2 more NDA approvals from USFDA.
2008
- Strides Arcolab receives third ANDA approval for Fosphenytoin Injection.
2010
- Mr. V. S. Iyer appointed as Executive Director.
2011
- Strides Arcolab receives USFDA approval to commercialize first sterile product.
- Strides Arcolab announces first European approval for oncology product.
- Strides Arcolab receives USFDA approval to commercialize first liquid product.
- Strides Arcolab updates on acquisition of minority shareholding in Ascent Pharmahealth Limited.
- Strides Arcolab joins Malaysian Bio-xcell Ecosystem.
2012
- Strides Arcolab receives USFDA approval for Brazilian Sterile facility.
- Strides Arcolab receives USFDA approval for Methotrexate Injection.
- Strides Arcolab receives Health Canada approval for Tobramycin Injection.
- Strides Arcolab acquires Sterile Formulations facility to expand injectable business.
- Strides Arcolab collaborates with Gilead Sciences.
2013
- Strides Arcolab receives USFDA ANDA approval for Tenofovir Disoproxil Fumarate and Emtricitabine Tablets.
- Strides Arcolab receives USFDA approval for Italian Semi-solids and Ointment facility.
- Strides receives WHO pre-qualification for Artemether + Lumifantrine.
- Stelis Biopharma and Pieris forge alliance for Anticalin Therapeutics in Ophthalmology.
- Strides Arcolab re-brands Biotech Business as 'Stelis'.
- Pfenex Inc. and Agila Biotech announce JV for biosimilar products.
2014
- Medicines for Malaria Venture announces collaboration with Strides.
- Strides Arcolab makes strategic investment in Oncobiologics Inc., USA.
- Strides partners with Gilead Sciences to bring Hepatitis C cure to 91 developing countries.
- Strides Arcolab receives USFDA approval for Buspirone Tablets.
- Strides Arcolab receives USFDA approval for Calcitriol Softgel.
- Strides Arcolab acquires 'Raricap' and India Branded Generic Business of Bafna.
- Strides Arcolab to acquire Shasun Pharma in all-stock deal.
2015
- Strides Arcolab enters agreement with Fortuna Public Relations as PR agency.
- Strides Arcolab enters licensing agreement with Gilead Sciences.
- Strides Arcolab launches generic Sofosbuvir 'Virso' in India.
- Strides Arcolab receives USFDA approval for Polyethylene Glycol 3350.
- Strides Arcolab receives USFDA approval for HIV treatment drug.
- Strides Arcolab approves merger of Shasun Pharmaceuticals.
- Strides Arcolab completes Rs 1,910-crore acquisition of Aspen Pharmacare, Australia.
- Strides Arcolab acquires CNS divisions of erstwhile Ranbaxy.
- Strides Arcolab changes name to Strides Shasun Limited.
2016
- Strides Shasun updates on acquisition of seven brands from Johnson & Johnson.
- Strides Shasun updates on acquisition of CNS divisions of erstwhile Ranbaxy.
- Strides Shasun to acquire strategic stake in Generic Partners Holdings, Australia.
- Strides Shasun to acquire controlling stake in Universal Corporation, Kenya.
- Strides Shasun receives USFDA tentative approval for Efavirenz Tablets.
- Strides Shasun announces successful US FDA inspection at Oral Dosage Facility in Bangalore.
2017
- Strides Shasun receives approval for Acetazolamide tablets.
- Strides receives approval for Omega-3-Acid Ethyl Esters capsules.
- Strides Shasun receives USFDA approval to launch allergy drug in US.
- Strides Shasun completes JV with Vivimed Labs.
2018
- Company name changed to Strides Pharma Science Ltd. from Strides Shasun Ltd.
- Strides receives USFDA approval for Polyethylene Glycol 3350 and Electrolytes for oral solution.
- Strides subsidiary inks pact with SUDA Pharmaceuticals for migraine drug.
- Strides receives USFDA approval for Potassium Chloride Extended Release Tablets.
2019
- Strides Pharma relaunches Ranitidine tablets in US.
- Strides Pharma Science arm receives USFDA approval for drug to treat overactive bladder.
- Strides Pharma acquires USFDA approved facility in US.
- Strides inks joint venture with China's Sihuan Pharma.
2020
- Strides Pharma Science receives USFDA approval for Prednisone tablets.
- Strides Pharma Science receives USFDA approval for generic anti-bacterial capsules.
- Strides arm receives EIR for US facility.
2021
- Stelis Biopharma commissions greenfield vaccine manufacturing facility at Bengaluru.
- Strides and TLC partner to launch black fungus drug in India.
- Strides Pharma arm receives USFDA approval for potassium chloride oral solution.
- Strides receives USFDA approval for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets.
2022
- Strides receives USFDA approval for Potassium Chloride Oral Solution.
- Strides receives USFDA approval for Naproxen Sodium OTC Softgel Capsules.
- Strides receives USFDA approval for Cyclosporine Softgel Capsules.
- Strides receives USFDA approval for Ibuprofen Oral Suspension.
- Strides partners with Medicines Patent Pool to commercialize generic Pfizer COVID-19 Oral Treatment across 95 markets.
2023
- Strides receives USFDA approval for Generic Suprep Bowel Prep Kit.
- Strides receives USFDA approval for Levetiracetam Oral Solution.
- Strides receives USFDA approval for Efavirenz, Emtricitabine & Tenofovir Disoproxil Fumarate tablets.
- Strides receives USFDA approval for Icosapent Ethyl Capsules.
- Strides receives tentative USFDA approval for Dolutegravir tablets.
2024
- Strides receives USFDA approval for Fluoxetine Tablets 60 mg.
- Strides Pharma unit receives USFDA approval for generic drug to treat gastrointestinal diseases.
- Strides receives USFDA approval for Theophylline Extended-Release Tablets 300 mg and 450 mg.
- Strides acquires balance stake in Strides Global Consumer Healthcare Limited, UK.
- Strides receives USFDA approval for Sucralfate Oral Suspension 1gm/10 mL.
- Strides receives USFDA approval for Sevelamer Carbonate Tablets 800 mg.
- Strides receives USFDA approval for Fluoxetine Tablets 10 mg and 20 mg.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800